Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1263 |
|---|---|
| Identifier | NCT05316220 |
| Trial Title | A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Mesalamine|DRUG: Placebo |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | District of Columbia |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-09-15 |
|---|---|
| Primary Completion Date | 2026-07-19 |
| Completion Date | 2026-07-19 |